P68 Mirikizumab versus placebo: histologic inflammation in 5 intestinal segments in randomized controlled phase 3 trial for crohn’s disease participants
Posters | June 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: A129.2-A130
10.1136/gutjnl-2025-bsg.204